
|Articles|August 6, 2013
Targeted Therapies in Oncology
- July 2013
- Volume 2
- Issue 4
ASCO Quick Reference Chart
Author(s)Anna Azvolinsky, PhD
A quick reference chart of the key clinical trials presented at the American Society of Clinical Oncology (ASCO) 2013 Annual Meeting.
Advertisement
Articles in this issue
over 12 years ago
NCCN Guidelines Updates: Solid Tumorsover 12 years ago
Targeted Advances in Melanomaover 12 years ago
NCCN Guidelines Updates: Hematologic Malignanciesover 12 years ago
Exploring the Potential for Expansion of Anti-HER2 Therapyover 12 years ago
The Changing Landscape of Oncology: Impact for Payers and Providersover 12 years ago
Positive Findings for Nab-Paclitaxel/Gemcitabine Combinationover 12 years ago
Changing Landscape for Genetic Testingover 12 years ago
Ibrutinib/R-CHOP Combination Achieves 100% Response Rate in NHLover 12 years ago
Ganetespib-Docetaxel Combination Improves SurvivalAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
2
Alpelisib/Fulvestrant Improves PFS in Post-CDK4/6 HR+/HER2- Breast Cancer
3
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
4
Real-World Pola-R-CHP vs R-CHOP Effectiveness in Older DLBCL Patients
5









































